TG Therapeutics, Inc. (BIT:1TGTX)
Italy
· Delayed Price · Currency is EUR 26.80
-0.71 (-2.58%)
At close: Dec 5, 2025
TG Therapeutics Revenue
TG Therapeutics had revenue of $161.71M USD in the quarter ending September 30, 2025, with 92.79% growth. This brings the company's revenue in the last twelve months to $531.90M, up 100.88% year-over-year. In the year 2024, TG Therapeutics had annual revenue of $329.00M with 40.80% growth.
Revenue (ttm)
$531.90M
Revenue Growth
+100.88%
P/S Ratio
8.53
Revenue / Employee
$1.57M
Employees
338
Market Cap
3.87B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 329.00M | 95.34M | 40.80% |
| Dec 31, 2023 | 233.66M | 230.88M | 8,290.02% |
| Dec 31, 2022 | 2.79M | -3.90M | -58.36% |
| Dec 31, 2021 | 6.69M | 6.54M | 4,300.66% |
| Dec 31, 2020 | 152.00K | - | - |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UniCredit | 24.85B |
| Intesa Sanpaolo | 25.32B |
| Enel SpA | 77.78B |
| Ferrari | 7.08B |
| Assicurazioni Generali | 56.79B |
| Eni S.p.A. | 86.56B |
| Stellantis | 146.12B |
| Leonardo S.p.a. | 19.13B |